{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:08:54Z","timestamp":1794006534010,"version":"4.8.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2034422"],"award-info":[{"award-number":["APP2034422"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1194334"],"award-info":[{"award-number":["APP1194334"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2033081"],"award-info":[{"award-number":["APP2033081"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001077","name":"Royal Brisbane and Women's Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","award":["APP1044900"],"award-info":[{"award-number":["APP1044900"]}],"id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","award":["APP1078121"],"award-info":[{"award-number":["APP1078121"]}],"id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024715","name":"Australia New Zealand Gynaecological Oncology Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024715","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijgc.2026.104725","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:08:59Z","timestamp":1777129739000},"page":"104725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-term oncological and reproductive outcomes following treatment with the levonorgestrel intra-uterine device for endometrial hyperplasia and adenocarcinoma: results from the feMMe phase 2 randomized clinical trial"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7685-8036","authenticated-orcid":false,"given":"Eva","family":"Baxter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0213-7652","authenticated-orcid":false,"given":"Kristy P.","family":"Robledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1728-8085","authenticated-orcid":false,"given":"Monika","family":"Janda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2199-1117","authenticated-orcid":false,"given":"Andreas","family":"Obermair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijgc.2026.104725_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.ijgc.2026.104725_bib2","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1158\/2159-8290.CD-24-1678","article-title":"Trends in cancer incidence and mortality rates in early-onset and older-onset age groups in the United States, 2010\u20132019","volume":"15","author":"Shiels","year":"2025","journal-title":"Cancer Discov"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104725_bib3","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1097\/AOG.0000000000005814","article-title":"Associated trends in obesity and endometrioid endometrial cancer in the United States","volume":"145","author":"Francoeur","year":"2025","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104725_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5468\/ogs.19169","article-title":"Fertility-sparing treatment in early endometrial cancer: current state and future strategies","volume":"63","author":"Obermair","year":"2020","journal-title":"Obstet Gynecol Sci"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104725_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40661-016-0023-8","article-title":"Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy","volume":"3","author":"Obermair","year":"2016","journal-title":"Gynecol Oncol Res Pract"},{"key":"10.1016\/j.ijgc.2026.104725_bib6","series-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Uterine Neoplasms v.1.2025","year":"2025"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104725_bib7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/ijgc-2022-004047","article-title":"ESGO\/ESHRE\/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma","volume":"33","author":"Rodolakis","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104725_bib8","doi-asserted-by":"crossref","first-page":"191.e1","DOI":"10.1016\/j.ajog.2020.08.032","article-title":"Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer","volume":"224","author":"Westin","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104725_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2021.01.029","article-title":"Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: results of a randomized clinical trial","volume":"161","author":"Janda","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104725_bib10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/IGC.0000000000001164","article-title":"Fertility-preserving treatment in young women with Grade 1 presumed stage IA endometrial adenocarcinoma: a meta-analysis","volume":"28","author":"Fan","year":"2018","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"10.1016\/j.ijgc.2026.104725_bib11","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1097\/IGC.0000000000000825","article-title":"Long-term oncologic and reproductive outcomes in young women with early endometrial cancer conservatively treated: a prospective study and literature update","volume":"26","author":"Laurelli","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"22","key":"10.1016\/j.ijgc.2026.104725_bib12","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1158\/1078-0432.CCR-24-0362","article-title":"Long-term follow-up of levonorgestrel intrauterine device for atypical hyperplasia and early endometrial cancer reveals relapse characterized by immune exhaustion","volume":"30","author":"Bowen","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104725_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/PAS.0000000000002492","article-title":"Central pathology review of endometrial hyperplasia and adenocarcinoma before and after treatment with the levonorgestrel intrauterine device-results from the feMMe Phase 2 randomized clinical trial","volume":"50","author":"Baxter","year":"2025","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104725_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cct.2014.06.014","article-title":"Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device \u00b1 metformin \u00b1 weight loss in endometrial cancer (feMME) trial","volume":"39","author":"Hawkes","year":"2014","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.ijgc.2026.104725_bib15","series-title":"Ggsurvfit: Flexible Time-to-Event Figures","author":"Sjoberg","year":"2025"},{"key":"10.1016\/j.ijgc.2026.104725_bib16","series-title":"Swimplot: Tools for Creating Swimmers Plots Using","author":"Weiss","year":"2021"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104725_bib17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med (Zagreb)"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104725_bib18","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.fertnstert.2021.08.018","article-title":"Obesity and reproduction: a committee opinion","volume":"116","year":"2021","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.ijgc.2026.104725_bib19","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/1471-0528.14491","article-title":"Abnormal mismatch repair and other clinicopathologic predictors of poor response to progestin treatment in young women with endometrial complex atypical hyperplasia and well-differentiated endometrial adenocarcinoma: a consecutive case series","volume":"124","author":"Zakhour","year":"2017","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104725_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.109570","article-title":"Oncologic and pregnancy outcomes of fertility-sparing treatment with medroxyprogesterone acetate in women with premalignant and malignant endometrial lesions: a case series","volume":"51","author":"Tofoski","year":"2024","journal-title":"Eur J Surg Oncol"},{"issue":"19","key":"10.1016\/j.ijgc.2026.104725_bib21","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ijgc.2026.104725_bib22","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/1471-0528.16108","article-title":"Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial","volume":"127","author":"Yang","year":"2020","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104725_bib23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/bjc.2013.766","article-title":"Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer","volume":"110","author":"Helpman","year":"2013","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.ijgc.2026.104725_bib24","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ejso.2016.03.009","article-title":"Accuracy of preoperative endometrial sampling diagnosis for predicting the final pathology grading in uterine endometrioid carcinoma","volume":"42","author":"Batista","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104725_bib25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ygyno.2008.07.033","article-title":"Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma","volume":"111","author":"Leitao","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104725_bib26","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jmig.2016.03.017","article-title":"Sampling in atypical endometrial hyperplasia: which method results in the lowest underestimation of endometrial cancer? A systematic review and meta-analysis","volume":"23","author":"Bourdel","year":"2016","journal-title":"J Minim Invasive Gynecol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104725_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.52054\/FVVO.14.2.023","article-title":"Endometrial biopsy under direct hysteroscopic visualisation versus blind endometrial sampling for the diagnosis of endometrial hyperplasia and cancer: systematic review and meta-analysis","volume":"14","author":"Di Spiezio Sardo","year":"2022","journal-title":"Facts Views Vis Obgyn"},{"issue":"7","key":"10.1016\/j.ijgc.2026.104725_bib28","article-title":"Fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer","volume":"7","author":"Fernandez-Montoli","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.ijgc.2026.104725_bib29","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ijgc-2020-001309","article-title":"Improving response to progestin treatment of low-grade endometrial cancer","volume":"30","author":"Baxter","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104725_bib30","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/AOG.0000000000005297","article-title":"Management of endometrial intraepithelial neoplasia or atypical endometrial hyperplasia: ACOG clinical consensus no. 5","volume":"142","year":"2023","journal-title":"Obstet Gynecol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26002562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26002562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:22:28Z","timestamp":1785356548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X26002562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1048891X26002562"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104725","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term oncological and reproductive outcomes following treatment with the levonorgestrel intra-uterine device for endometrial hyperplasia and adenocarcinoma: results from the feMMe phase 2 randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of European Society of Gynaecological Oncology and the International Gynecologic Cancer Society.","name":"copyright","label":"Copyright"}],"article-number":"104725"}}